EMJ GOLD

Filter Advertise With Us

A hospital room with a patient resting in a bed while a healthcare worker and another visitor sit nearby. In the foreground, a bright yellow medical transport bag sits on a table, with monitoring equipment and clinical furnishings visible around the room.

World-first trial delivers personalised lung cancer vaccine

The first patient has received a personalised lung cancer vaccine in a world-first clinical trial for advanced non-small cell lung cancer.

Johnson & Johnson secures FDA nod for OTTAVA system

J&J receives FDA De Novo authorization for OTTAVA robotic surgical system, launching platform for soft tissue surgery in the US.

Q2 growth for Novartis as new drugs offset patent cliff

The company has reported sales growth of 3% in US dollar terms, as newer medicines offset patent losses.

BMS strengthens AI driven drug discovery

Expanded AI infrastructure was introduced to strengthen artificial intelligence driven drug discovery, improve computational efficiency, and support the development of advanced research models across multiple therapeutic areas.

EMJ shortlisted for Marketing Week Awards 2026

EMJ has been named a finalist in the Excellence in Health and Life Sciences category for its work with PARI Pharma GmbH.

Merck wins FDA nod for enlicitide oral cholesterol pill

Merck’s enlicitide has received FDA approval as the first oral PCSK9 inhibitor for lowering LDL-C in adults with hypercholesterolemia.

Eli Lilly takes a leap into toad venom science

Lilly to buy AtaiBeckley for up to $3.8bn, gaining a psychedelic compound associated with Colorado River toad venom.

NICE Draft Guidance Backs Finerenone for HFpEF - EMJ

NICE backs finerenone for heart failure in draft guidance

NICE has issued draft guidance recommending finerenone for adults with heart failure with preserved or mildly reduced ejection fraction, pending final approval.

AstraZeneca office building external

AZ licenses Dizal's lung cancer drug in $1.5bn deal

AstraZeneca has struck a $1.5bn agreement with Shanghai-based Dizal Pharmaceutical for sunvozertinib.

Loading posts...

« Previous 1 2 3 4 … 57 Next »